University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular ...
Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.
Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.
University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular ...
Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heart disease called left ventricular ...
Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...
Nonischemic cardiomyopathy is when problems with your heart muscle aren’t due to reduced blood flow. Instead, causes include genetics, infections, and autoimmune conditions. Cardiomyopathy is the ...
Cardiomyopathy is a disease that involves a weakened heart muscle. The condition makes it difficult for the heart to pump blood throughout the body. According to the Centers for Disease Control and ...
A change in clinical practice could bring benefits for young elite athletes with the use of a novel new screening tool for cardiomyopathy, a cardiac condition that researchers said was "frequently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results